Profusa, Inc. Common Stock(PFSA)

Medical - Devices · Berkeley, CA

$1.70-0.05 (-3.14%)

Delayed quote: Oct 6, 2026, 1:29 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T17:33:36.457Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:33:36.457Z.

Quote observation: 2026-10-06T17:29:27.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 1.695
Unrounded diluted TTM EPS · period ending 2026-06-30: -213.25

FMP input reference: f8447282adf6e47d1ec21ed7020f0f216562717f012d53baf90ed137265b4b00

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

PFSA PE Ratio Metrics

PE RATIO

N/A

PFSA Competitors' PE Ratio

PFSA

Profusa, Inc. Common Stock

Current

Market Cap

$1.87M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RNAZ

TransCode Therapeutics, Inc.

vs PFSA

Market Cap

$1.88M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TNON

Tenon Medical, Inc.

vs PFSA

Market Cap

$1.85M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TCRT

Alaunos Therapeutics, Inc.

vs PFSA

Market Cap

$1.89M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AMIX

Autonomix Medical, Inc.

vs PFSA

Market Cap

$1.93M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

XAIR

Beyond Air, Inc.

vs PFSA

Market Cap

$1.93M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GOVX

GeoVax Labs, Inc.

vs PFSA

Market Cap

$2.07M

PE Ratio

N/A

TTM Avg

98120994617.14

3Y Avg

98120994617.14

5Y Avg

98120994617.14

SILO

Silo Pharma, Inc.

vs PFSA

Market Cap

$1.58M

PE Ratio

N/A

TTM Avg

4.04

3Y Avg

4.04

5Y Avg

4.04

ELAB

PMGC Holdings Inc.

vs PFSA

Market Cap

$1.49M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRIS

Curis, Inc.

vs PFSA

Market Cap

$1.48M

PE Ratio

N/A

TTM Avg

47.01

3Y Avg

47.01

5Y Avg

34.74

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Profusa, Inc. Common Stock (PFSA)	$1.87M	N/A	N/A	N/A	N/A
TransCode Therapeutics, Inc. (RNAZ)vs ›	$1.88M	N/A	N/A	N/A	N/A
Tenon Medical, Inc. (TNON)vs ›	$1.85M	N/A	N/A	N/A	N/A
Alaunos Therapeutics, Inc. (TCRT)vs ›	$1.89M	N/A	N/A	N/A	N/A
Autonomix Medical, Inc. (AMIX)vs ›	$1.93M	N/A	N/A	N/A	N/A
Beyond Air, Inc. (XAIR)vs ›	$1.93M	N/A	N/A	N/A	N/A
GeoVax Labs, Inc. (GOVX)vs ›	$2.07M	N/A	98120994617.14	98120994617.14	98120994617.14
Silo Pharma, Inc. (SILO)vs ›	$1.58M	N/A	4.04	4.04	4.04
PMGC Holdings Inc. (ELAB)vs ›	$1.49M	N/A	N/A	N/A	N/A
Curis, Inc. (CRIS)vs ›	$1.48M	N/A	47.01	47.01	34.74

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

PFSA PE Ratio Metrics

PFSA Competitors' PE Ratio

P/E Comparison

PE Ratio Formula & Definition

Related Metrics